U.S. Imposes Sanctions on Myanmar, Affecting Pharmaceutical Trade
The United States has imposed new sanctions on Myanmar due to ongoing political unrest, targeting specific sectors including limited restrictions on pharmaceutical products under HS Code Chapter 30.
2023-10-15
Impact: Trade of pharmaceuticals between the U.S. and Myanmar may face delays or restrictions, impacting supply chains for essential medicines.
Myanmar's Export of Medicinal Products to the U.S. Under Review
U.S. authorities are reviewing imports of medicinal and pharmaceutical products from Myanmar under Chapter 30 due to concerns over compliance with international standards.
2023-09-20
Impact: Potential temporary halts or stricter inspections could disrupt the flow of pharmaceutical goods from Myanmar to the U.S.
U.S. Aid Package Includes Pharmaceutical Support to Myanmar
As part of a humanitarian aid package, the U.S. has pledged support for pharmaceutical supplies to Myanmar, categorized under HS Code Chapter 30, to address health crises.
2023-08-05
Impact: This could temporarily boost the import of U.S. pharmaceutical products to Myanmar, though distribution challenges remain due to political instability.
